Ubiquitination-resistant p53 protein transduction therapy facilitates anti-cancer effect on the growth of human malignant glioma cells.

Michiue, Hiroyuki

Ubiquitination-resistant p53 protein transduction therapy facilitates anti-cancer effect on the growth of human malignant glioma cells. [electronic resource] - FEBS letters Jul 2005 - 3965-9 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0014-5793

10.1016/j.febslet.2005.06.021 doi


Adenoviridae--genetics
Antineoplastic Agents--pharmacology
Blotting, Western
Brain Neoplasms--pathology
Cell Line, Tumor
Cell Survival
DNA, Complementary--metabolism
Dose-Response Relationship, Drug
Genes, Reporter--genetics
Genes, p53
Genetic Therapy--methods
Glioma--pathology
Humans
In Situ Nick-End Labeling
Mutagenesis, Site-Directed
Peptides--chemistry
Protein Structure, Tertiary
Recombinant Fusion Proteins--metabolism
Time Factors
Transcription, Genetic
Tumor Suppressor Protein p53--metabolism
Ubiquitin--chemistry